Schonfeld Strategic Advisors LLC Tg Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 270,284 shares of TGTX stock, worth $6.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
270,284
Previous 491,098 44.96%
Holding current value
$6.56 Million
Previous $7.47 Million 35.63%
% of portfolio
0.03%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $2.94 Million - $4.24 Million
-220,814 Reduced 44.96%
270,284 $4.81 Million
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $2 Million - $3.28 Million
153,949 Added 45.66%
491,098 $7.47 Million
Q4 2023

Feb 14, 2024
SELL
$6.68 - $18.81 $6.88 Million - $19.4 Million
-1,030,251 Reduced 75.34%
337,149 $5.76 Million
Q3 2023

Nov 14, 2023
BUY
$8.36 - $26.5 $7.11 Million - $22.5 Million
850,507 Added 164.54%
1,367,400 $11.4 Million
Q2 2023

Aug 14, 2023
SELL
$15.48 - $35.0 $8.49 Million - $19.2 Million
-548,320 Reduced 51.48%
516,893 $12.8 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $19.34 $10.3 Million - $19.4 Million
1,002,213 Added 1590.81%
1,065,213 $16 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $118,496 - $279,803
23,652 Added 60.11%
63,000 $745,000
Q3 2022

Nov 14, 2022
SELL
$4.57 - $8.4 $1.81 Million - $3.33 Million
-396,983 Reduced 90.98%
39,348 $233,000
Q2 2022

Aug 15, 2022
BUY
$3.74 - $10.66 $1.63 Million - $4.65 Million
436,331 New
436,331 $1.85 Million
Q1 2021

May 17, 2021
SELL
$41.61 - $54.3 $979,374 - $1.28 Million
-23,537 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$25.27 - $54.9 $594,779 - $1.29 Million
23,537 New
23,537 $1.22 Million
Q3 2020

Nov 16, 2020
SELL
$18.49 - $27.24 $822,416 - $1.21 Million
-44,479 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$8.9 - $21.84 $207,022 - $508,020
23,261 Added 109.63%
44,479 $867,000
Q1 2020

May 15, 2020
BUY
$7.14 - $15.99 $151,496 - $339,275
21,218 New
21,218 $209,000
Q2 2018

Aug 14, 2018
SELL
$12.5 - $15.0 $415,962 - $499,155
-33,277 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$8.7 - $16.8 $289,509 - $559,053
33,277 New
33,277 $472,000

Others Institutions Holding TGTX

# of Institutions
292
Shares Held
91.9M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.52B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email